Abstract
Background
Effectiveness and tolerability of psychiatric medications are not only determined by the drug’s pharmacological profile but through the interaction of different factors, including patients’ attitudes toward their prescribed medications. Increased knowledge about those attitudes may help prescribers to improve patient concordance and thereby the effectiveness of the pharmacological therapy.
Objective
The goal of this study was to assess stable psychiatric outpatients’ attitudes toward psychiatric drug treatment and to what extent patients and public opinions on this subject diverge as a consequence of being on this type of medication.
Methods
Two anonymous self-reported questionnaires [Drug Attitude Inventory (DAI)-10 and an abridge version of Beliefs about Medicines Questionnaire (BMQ)] were administered to 270 stable psychiatric outpatients under treatment and 292 citizens naïve to psychotropic medication.
Results
Psychiatric patients showed a more positive attitude toward medication (DAI score 3.6 vs. −0.7; range −10 to +10; negative to positive). Up to 77% of patients showed positive scores compared with only 36% in the general population. Multiple regression analysis showed that none of the variables in the analysis have a predictive value with regard to the attitude toward psychiatric drugs used.
Conclusion
The continuous use of psychotropic medication shapes the opinion of the users toward a more beneficial perception of medications, but the opinion on the general population, where stigmatizing attitudes are born, is more negative toward them. For psychiatrists and their patients, trying to achieve a better understanding of each other’s expectations and reaching concordance is mandatory.
Similar content being viewed by others
References
Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC (2004) Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry 65(10):1372–1376
Angermeyer MC, Matschinger H (2005) Have there been any changes in the public’s attitudes towards psychiatric treatment? Results from representative population surveys in Germany in the years 1990 and 2001. Acta Psychiatr Scand 111(1):68–73
Angermeyer MC, Breier P, Dietrich S, Kenzine D, Matschinger H (2005) Public attitudes toward psychiatric treatment. An international comparison. Soc Psychiatry Psychiatr Epidemiol 40(11):855–864
Triandis HC (1971) Attitude and attitude change. Wiley, New York
Hogan TP, Awad AG, Eastwood R (1983) A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13(1):177–183
Hogan TP, Awad AG (1992) Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 22(2):347–352
Horne, Weinman J, Hankins M (1996) The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14:1–24
Angermeyer MC, Daumer R, Matschinger H (1993) Benefits and risks of psychotropic medication in the eyes of the general public: results of a survey in the Federal Republic of Germany. Pharmacopsychiatry 26(4):114–120
Benkert O, Graf-Morgenstern M, Hillert A, Sandmann J, Ehmig SC, Weissbecker H et al (1997) Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection. J Nerv Ment Dis 185(3):151–158
Jorm AF, Korten AE, Jacomb PA, Rodgers B, Pollitt P, Christensen H et al (1997) Helpfulness of interventions for mental disorders: beliefs of health professionals compared with the general public. Br J Psychiatry 171:233–237
Sajatovic M, Rosch DS, Sivec HJ, Sultana D, Smith DA, Alamir S et al (2002) Insight into illness and attitudes toward medications among inpatients with schizophrenia. Psychiatr Serv 53(10):1319–1321
Hoencamp E, Stevens A, Haffmans J (2002) Patients’ attitudes toward antidepressants. Psychiatr Serv 53(9):1180–1181
Gordon D, Alexander DA, Dietzan J (1979) The psychiatric patient: a voice to be heard. Br J Psychiatry 135:115–121
Hofer A, Fleischhacker WW (2006) Attitudes towards medication in patients with schizophrenia. Acta Psychiatr Scand 113(3):161–162
Blenkinsopp A, Bond C, Britten N, Feely M, George C, Green P et al (1997) From compliance to concordance. Achieving shared goals in medicine taking. A working party report. Royal Pharmaceutical Society of Great Britain and Merck Sharp and Dohme, London
Sanz E (2005) Patient adherence to medical treatment regimens. Bridging the gap between behavioural science and biomedicine (Book Review). BMJ 330(7500):1155
Sanz EJ (2003) Concordance and children’s use of medicines. BMJ 327(7419):858–860
Dickinson D, Wilkie P, Harris M (1999) Taking medicines: concordance is not compliance. BMJ 319(7212):787
Conflict of interest statement
This study received no funding. We have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De las Cuevas, C., Sanz, E.J. Attitudes toward psychiatric drug treatment: the experience of being treated. Eur J Clin Pharmacol 63, 1063–1067 (2007). https://doi.org/10.1007/s00228-007-0358-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-007-0358-5